Institutional & Family Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1
| Closed | -$962 | – | 777 |
|
|
2024
Q1 | $962 | Hold |
1
| – | – | ﹤0.01% | 643 |
|
|
2023
Q4 | $878 | Hold |
1
| – | – | ﹤0.01% | 624 |
|
|
2023
Q3 | $823 | Hold |
1
| – | – | ﹤0.01% | 627 |
|
|
2023
Q2 | $719 | Hold |
1
| – | – | ﹤0.01% | 651 |
|
|
2023
Q1 | $822 | Hold |
1
| – | – | ﹤0.01% | 647 |
|
|
2022
Q4 | $721 | Hold |
1
| – | – | ﹤0.01% | 631 |
|
|
2022
Q3 | $1K | Hold |
1
| – | – | ﹤0.01% | 670 |
|
|
2022
Q2 | $1K | Hold |
1
| – | – | ﹤0.01% | 688 |
|
|
2022
Q1 | $1K | Hold |
1
| – | – | ﹤0.01% | 724 |
|
|
2021
Q4 | $1K | Hold |
1
| – | – | ﹤0.01% | 753 |
|
|
2021
Q3 | $1K | Hold |
1
| – | – | ﹤0.01% | 868 |
|
|
2021
Q2 | $1K | Hold |
1
| – | – | ﹤0.01% | 912 |
|
|
2021
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 985 |
|
|
2020
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 916 |
|
|
2020
Q3 | $1K | Hold |
1
| – | – | ﹤0.01% | 808 |
|
|
2020
Q2 | $1K | Hold |
1
| – | – | ﹤0.01% | 798 |
|
|
2020
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 890 |
|
|
2019
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 884 |
|
|
2019
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 874 |
|
|
2019
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 870 |
|
|
2019
Q1 | $0 | Sell |
1
-48
| -98% | -$19.8K | ﹤0.01% | 871 |
|
|
2018
Q4 | $18K | Sell |
49
-4
| -8% | -$1.46K | ﹤0.01% | 419 |
|
|
2018
Q3 | $21K | Hold |
53
| – | – | ﹤0.01% | 434 |
|
|
2018
Q2 | $18K | Hold |
53
| – | – | ﹤0.01% | 451 |
|
|
2018
Q1 | $18K | Buy |
+53
| New | +$18.4K | ﹤0.01% | 429 |
|
Other funds holding REGN
